Weichang’an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer—Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1

  • Chuan Fang Pan
  • , Xi Zhang
  • , Jing Wen Wang
  • , Tao Yang
  • , Linda L. D. Zhong*
  • , Ke Ping Shen*
  • *Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Weichang’an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer—Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1'. Together they form a unique fingerprint.
Sort by:

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science